TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Allos Therapeutics, Inc. Merger Under Investor Investigation

  • If you purchased shares of Allos Therapeutics, Inc. (NASDAQ: ALTH) prior to the announcement and currently hold those shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

April 5, 2012 (Update) -- On Apr. 5, 2012, Spectrum Pharmaceuticals (NASDAQ: SPPI) and Allos Therapeutics, Inc. (NASDAQ: ALTH) announced that they have signed an agreement under which Spectrum Pharmaceuticals will acquire all of the outstanding shares of Allos Therapeutics for $1.82 per share in cash plus one Contingent Value Right (CVR). This CVR entitles Allos stockholders to an add...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: